Status:

COMPLETED

Exercise in Men Receiving Radiation Therapy for Prostate Cancer.

Lead Sponsor:

Ottawa Hospital Research Institute

Collaborating Sponsors:

Canadian Cancer Trials Group

Conditions:

Prostatic Neoplasms

Eligibility:

MALE

Phase:

NA

Brief Summary

Androgen Deprivation Therapy is a commonly used treatment for men with Prostate Cancer. Unfortunately this can lead to functional decline, fatigue, increased body fatness, loss of lean body tissue and...

Detailed Description

A total of 220 men with a diagnosis of prostate cancer, scheduled to receive radiation will be recruited. The study is a parallel 3-group design with groups stratified for intended duration of ADT ( g...

Eligibility Criteria

Inclusion

  • Prostate Cancer
  • Radiation Therapy with curative Intent
  • ADT

Exclusion

  • Contraindication to exercise
  • Uncontrolled hypertension
  • Uncontrolled Cardiac Disease
  • Uncontrolled psychotic condition
  • Unable to obtain informed consent

Key Trial Info

Start Date :

June 1 2002

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2009

Estimated Enrollment :

121 Patients enrolled

Trial Details

Trial ID

NCT00253916

Start Date

June 1 2002

End Date

July 1 2009

Last Update

April 21 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Ottawa Hospital-Integrated Cancer Program

Ottawa, Ontario, Canada, K1H-1C4